ASSUTA
They do this by checking the patient ' s medical and family history and genetic tests . " Then we build a specific plan for each patient , for prevention or for screening and testing over the coming years , that enables us to detect the occurrence of the medical condition before it is becomes symptomatic . For example , a lot of different oncology patients may have some history of breast cancer or colon cancer in the family . If we know the risk of a patient , we can decide when this patient should come to Assuta and conduct different diagnostic tests , such as an MRI , mammography , different blood tests , colonoscopy or ultrasound tests . Then we can build a personally tailored screening plan according to what we learn from this ."
Accelerating collaborations as the key to achieving future clinical goals In the next few years Assuta ' s main goals are to continue driving patient-centred care and choice . " We want to give our patients the personalised care that they need , and be leaders in this approach , in Israel but also for the world . For doing so we will accelerate our collaborations with industry partners ." Dr Guindy says .
" We believe that a smooth collaboration between developers , medical teams and healthcare organisations is the key for success when developing clinical technologies . We hope that Assuta ’ s holistic combination of elements and assets , together with RISE ’ s agility and expertise , will allow our clinical workflows to be more accessible for R & D collaborations while allowing us to continue to set the standard of quality of care and patient experience for the Israeli healthcare system and for other systems around the globe .”
healthcareglobal . com 77